Reco
Cybersecurity software that helps security teams discover, govern and secure SaaS applications, identities and AI agents.
$55MSeries B extension
ParticipantQC
Quadrille Capital
Activity from announced rounds
Activity in this selectionOct 18, 2026 · Jul 21, 2026
Quadrille Capital is a technology and healthcare investment manager whose own feed confirms Reco and Adonis.
Recorded funding activity
Reco secures SaaS systems and agents. Adonis helps providers recover reimbursement, while BigHat engineers antibody medicines. These companies address different security, financial and biological problems.
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $130M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionBigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
Participant